This trial is testing a new device to treat atrial fibrillation, a common heart rhythm disorder.
- Atrial Fibrillation
10 Primary · 0 Secondary · Reporting Duration: 360 Days
1 Treatment Group
Pulsed Field Ablation
1 of 1
417 Total Participants · 1 Treatment Group
Primary Treatment: Pulsed Field Ablation · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is it possible to sign up for this medical experiment currently?
"According to clinicaltrials.gov, this study is still recruiting participants and was first launched on March 2nd 2023 with the most recent update occuring on the same day." - Anonymous Online Contributor
How many participants are actively engaged in the research project?
"The sponsor, Boston Scientific Corporation will be managing this medical trial from multiple locations including Banner University Medical Centre Phoenix-Hospital in Arizona and Arrhythmia Research Group-Research Facility in Arkansas. To successfully conclude the study, a total of 417 qualified patients must take part." - Anonymous Online Contributor
Are there a great number of hospitals running this trial across North America?
"The following medical centres are actively recruiting for this study: Banner University Medical Center Phoenix-Hospital located in Phoenix, Arizona; Arrhythmia Research Group-Research Facility situated in Jonesboro, Arkansas; and Scripps Memorial Hospital-Hospital found in La Jolla, California. There are another 53 sites that have opened recruitment to participants as well." - Anonymous Online Contributor